Andreas Bohrer

Prof. Dr. iur., Attorney, LL.M.

Mobile +41 79 865 8567 Group General Counsel [email protected] and Company Secretary [email protected] SSRN Publications of Andreas Bohrer Lonza Group AG, University of Zurich website Andreas Bohrer Vanguard Law Magazine featuring Andreas Bohrer

Expertise: Education: Andreas Bohrer is Group General Counsel and 2011 Harvard Executive Forum, USA Company Secretary at Lonza Group AG. Previously 2011 Titularprofessor, University of Zurich with , UBS, law firms in Zurich/Geneva and 2008 INSEAD, IEP, Paris/Singapore New York. Titularprofessor at Zurich University, lecturer on Corporate Governance and Capital Markets law. 2004 Habilitation, University of Zurich 1997/98 LL.M. (NYU); Fulbright Scholar Practice Areas: 1995-97 Dr. iur.; bar exam; lic. iur., Zurich General Counsel roles in Pharma, Banking and Asset Management. Board and Corporate Governance Board-related Experience: experience. M&A/Transactions in US and . – Company Secretary of Lonza, a Swiss SMI® Professional Experience: blue chip company with dual listing (Board and Executive Committee). IMD Board Education 2015- Group General Counsel and Company Program, Lausanne 2015 Lonza Secretary, Lonza Group (Swiss SMI® blue chip company with dual listing), – Board member in banking and non-financial reporting to the CEO. Acquisition / sector (including venture incubator) integration of Capsugel. – Member of various Group subsidiary boards in In charge of Legal, Ethics&Compliance Switzerland and world-wide, in the financial and and IP, Environment/Health/Safety non-financial sector. (EHS) and Sustainability, Region India

and South America. Extra-curricular activities, networks: – Member of the Board of SwissHoldings, the 2010-15 2014-2015, General Counsel and Association of industrial and service groups in Novartis member of the Executive Committee, Switzerland, 2015-2017. Co-Chair of Corporate Novartis Animal Health Division. In and Capital Market Law Committee, 2018- charge of Legal, Compliance and IP globally. Integration into Eli Lilly & Co. – Pro bono Trustee, Stiftung Europainstitut of the University of Basel; Co-Chair, Internationale 2010-2014, Head Legal Transactions, Bach-Gesellschaft (IBG) Schaffhausen. Novartis Group: M&A, VC, Antitrust, – Alumnus, American-Swiss Young Leaders Capital Markets & Corporate Law, Conference, 2009; Stars – the Symposium for Procurement, IT & Outsourcing, Social Leaders of the Next Generation, 2012. Media, HR. USD 50bn acquisition of by Novartis. – Military: 1st lieutenant, intelligence officer, air transport squadron, Swiss Air Force (until 2005) 2003-10 2009-2010, General Counsel Switzer- – Languages: German and English (fluent); land, UBS AG. Member of Executive UBS French and Italian (intermediate); Chinese Committee UBS Switzerland. (Mandarin) and Russian (beginner). 2004-2009, General Counsel and Chief Risk Officer EMEA, UBS Global Publications & Academic activities: Asset Management. Member of the – Max Planck Institute, Hamburg, yearly European Management Committee. German/Austrian/Swiss corporate and capital 2003-2004, Executive Director with market law expert symposium, since 2010 UBS Group Legal in Zurich, in charge – Harvard & Stanford Law Schools, USA, 2009 of the UBS own-account M&A. International Junior Faculty Forum 1999-2003 Corporate attorney with Lenz & – Habilitation thesis „Corporate Governance Staehelin in Zurich and Geneva. and Capital Market Transactions“, Zurich 2005 1995-1997 Trainee/associate (incl. bar exam). – Ph.D. thesis on Unfriendly Takeovers under 1998-99 Corporate associate with Covington & Swiss law, Zurich 1997 Burling (Howard Smith & Levin) in – Winner of a First Prize of the Zurich University New York. Prize Institute, 1993.